potent activity against a375 (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
99
Structured Review
ATCC
potent activity against a375
Potent Activity Against A375, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 5277 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/potent+activity+against+a375/A-375/pmc09850771-35-46-27
Average 99 stars, based on 5277 article reviews
Potent Activity Against A375, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 5277 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/potent+activity+against+a375/A-375/pmc09850771-35-46-27
Average 99 stars, based on 5277 article reviews
potent activity against a375 - by Bioz Stars,
2026-11
99/100 stars
Images
1) Product Images from "Design, synthesis, anticancer and in silico assessment of 8-caffeinyl-triazolylmethoxy hybrid conjugates † "
Article Title: Design, synthesis, anticancer and in silico assessment of 8-caffeinyl-triazolylmethoxy hybrid conjugates
Journal: RSC Advances
doi: 10.1039/d2ra07683g
Figure Legend Snippet: The cytotoxic activity of 22a–22j and MTX against A-375, MCF7 and MDA-MB-468 and HEK-293 cell lines
Techniques Used: Activity Assay
Figure Legend Snippet: (A) The viability assessment for 22a–22j and MTX against A375. (B) The viability assessment for 22a–22j and MTX against MCF7. (C) The viability assessment for 22a–22j and MTX against MDA-MB-468. (D) The viability assessment for 22a–22j and MTX against HEK-293.
Techniques Used:
Related Articles
In Vitro:Article Title: Design, synthesis, anticancer and in silico assessment of 8-caffeinyl-triazolylmethoxy hybrid conjugates Article Snippet: .. The in vitro evaluations of synthesized compounds on cancer cell lines, including two breast cancer cell lines MDA-MB-468 (ATCC HTB-22), MCF-7 (ATCC HTB-22), melanoma cell line A-375 (ATCC CRL-1619) and normal cell line HEK-293 (ATCC CRL-11268) have determined that 22c (IC 50 < 12.5 μM) demonstrated Synthesized:Article Title: Design, synthesis, anticancer and in silico assessment of 8-caffeinyl-triazolylmethoxy hybrid conjugates Article Snippet: .. The in vitro evaluations of synthesized compounds on cancer cell lines, including two breast cancer cell lines MDA-MB-468 (ATCC HTB-22), MCF-7 (ATCC HTB-22), melanoma cell line A-375 (ATCC CRL-1619) and normal cell line HEK-293 (ATCC CRL-11268) have determined that 22c (IC 50 < 12.5 μM) demonstrated Multiple Displacement Amplification:Article Title: Design, synthesis, anticancer and in silico assessment of 8-caffeinyl-triazolylmethoxy hybrid conjugates Article Snippet: .. The in vitro evaluations of synthesized compounds on cancer cell lines, including two breast cancer cell lines MDA-MB-468 (ATCC HTB-22), MCF-7 (ATCC HTB-22), melanoma cell line A-375 (ATCC CRL-1619) and normal cell line HEK-293 (ATCC CRL-11268) have determined that 22c (IC 50 < 12.5 μM) demonstrated Activity Assay:Article Title: Design, synthesis, anticancer and in silico assessment of 8-caffeinyl-triazolylmethoxy hybrid conjugates Article Snippet: .. The in vitro evaluations of synthesized compounds on cancer cell lines, including two breast cancer cell lines MDA-MB-468 (ATCC HTB-22), MCF-7 (ATCC HTB-22), melanoma cell line A-375 (ATCC CRL-1619) and normal cell line HEK-293 (ATCC CRL-11268) have determined that 22c (IC 50 < 12.5 μM) demonstrated |